Rare diseases
Investigational molecules
Locations
Study of Cemiplimab, Platinum and Gemcitabine in Treatment‑Naïve Patients with Advanced Squamous Non‑Small Cell Lung Cancer
ItalyAnakinra for patients with myeloproliferative neoplasms resistant to cytoreductive therapy: a study to improve treatment response
FranceDurvalumab personalized consolidation immunotherapy after chemoradiotherapy in patients with stage III non‑small cell lung cancer
FranceStudy of apremilast‑induced headache and migraine in women with migraine without aura
DenmarkHigh-dose insulin lispro, potassium chloride and glucose treatment for patients with non‑toxic acute cardiogenic shock
NorwayStudy of IDE849, IDE‑161 and durvalumab evaluating safety and efficacy in patients with DLL3‑positive tumors including small cell lung cancer
FranceA Randomized Controlled Trial of Cannabidiol vs Placebo Augmentation in Patients with First Episode Psychosis
AustriaDalbavancin versus standard drug combination for treatment of infective endocarditis caused by Gram‑positive cocci in adult patients
GermanyMicronised progesterone luteal-phase support improves live birth rates in women with unexplained infertility
The NetherlandsSafety and Tolerability of Intrathecal ION337 in Patients with Dravet Syndrome
BelgiumSafety and Tolerability of Inhaled KB707 with or without Docetaxel in Patients with Advanced Lung Solid Tumors
FrancePhase 3 Study of Taletrectinib as Adjuvant Therapy in Patients with Completely Resected ROS1‑Positive Stage IB‑IIIA Non‑Small Cell Lung Cancer
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
